{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:08:46Z","timestamp":1779127726095,"version":"3.51.4"},"reference-count":81,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>The Dapivirine Vaginal Ring (DVR), a silicone circular ring, continuously distributes Dapivirine into the vagina to prevent HIV infection. We summarized evidence on adherence to DVR for HIV-1 prevention among African women 16\u201345 years old and described the factors associated with adherence. We searched different databased from inception to December 2024. We included observational studies and randomized trials. Our primary outcome was adherence to DVR, explored as women adhering, mean adherence, and visit\/ring adherence. Pairs of reviewers independently screened for eligible studies and extracted relevant data. We performed a random-effects meta-analysis of proportions and means for DVR adherence. The certainty of the evidence was assessed using the GRADE approach. Our search retrieved 217 records, of which 15 articles published between 2016 and 2024 were found (seven unique studies). Across the seven included studies, 2,424 women using DVR were reported in four studies. Across the included studies, adherence to the vaginal ring was measured as proportion with good adherence (4 studies), mean adherence (1 study), number of follow-ups with good adherence (1 study); and 1 study reported both mean adherence and number of returned rings deemed adherent. Adherence to the DVR among women was generally good, with a pooled mean estimate of 84% (95% CI: 75%\u201391%), although the certainty of evidence was very low. The proportion of women who adhered was 76% (95% CI: 63%\u201387%). Appropriate use of rings was 74% (95% CI 74\u201375%) and visits with adherence reported was 89% (95% CI 89\u201390%). Factors influencing adherence were cross-cutting across multiple domains. The evidence suggests generally good adherence to the DVR, which may enhance its effectiveness in reducing HIV infections in real-world settings; however, the certainty of this evidence is low. We encourage further implementation research, particularly individual patient data meta-analyses, to assess adherence more accurately.<\/jats:p>","DOI":"10.1371\/journal.pgph.0006422","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:33:56Z","timestamp":1779125636000},"page":"e0006422","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estimated adherence to the Dapivirine Vaginal Ring and its associated factors among African women: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8210-9258","authenticated-orcid":true,"given":"Roseline Dzekem","family":"Dine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4618-0839","authenticated-orcid":true,"given":"Giulia M.","family":"Muraca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9422-5232","authenticated-orcid":true,"given":"Behnam","family":"Sadeghirad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Couban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agatha","family":"Nyambi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6896-9473","authenticated-orcid":true,"given":"J\u00e9ssyca","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Mbuagbaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"pgph.0006422.ref001","unstructured":"UNAIDS. Global HIV & AIDS statistics \u2014 Fact sheet [Internet]. [cited 2024 Jun 11]. Available from: https:\/\/www.unaids.org\/en\/resources\/fact-sheet"},{"key":"pgph.0006422.ref002","unstructured":"CDC. Pre-Exposure Prophylaxis (PrEP) | HIV Risk and Prevention | HIV\/AIDS | CDC [Internet]. 2023 [cited 2024 Jun 11]. Available from: https:\/\/www.cdc.gov\/hiv\/risk\/prep\/index.html"},{"issue":"2","key":"pgph.0006422.ref003","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(20)30304-0","article-title":"Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study","volume":"8","author":"JM Baeten","year":"2021","journal-title":"Lancet HIV"},{"key":"pgph.0006422.ref004","unstructured":"NIH. Pre-Exposure Prophylaxis (PrEP) to Prevent HIV | NIAID: National Institute of Allergy and Infectious Diseases [Internet]. 2024 [cited 2024 Jun 11]. Available from: https:\/\/www.niaid.nih.gov\/diseases-conditions\/pre-exposure-prophylaxis-prep"},{"issue":"3","key":"pgph.0006422.ref005","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s10461-017-1955-7","article-title":"Brief participant-centered convergence interviews integrate self-reports, product returns, and pharmacokinetic results to improve adherence measurement in MTN-017","volume":"22","author":"IC Bal\u00e1n","year":"2018","journal-title":"AIDS Behav"},{"key":"pgph.0006422.ref006","unstructured":"WHO. HIV and AIDS [Internet]. [cited 2024 Jun 11]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids?gad_source=1&gclid=CjwKCAjw65-zBhBkEiwAjrqRMBdZtIajutR5N-M2bPn_Qys-QXoSBzUpC7pfNatSMcubgYPrjwVmSRoCWxoQAvD_BwE"},{"issue":"5","key":"pgph.0006422.ref007","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/cid\/ciw832","article-title":"MTN-017: a rectal phase 2 extended safety and acceptability study of tenofovir reduced-glycerin 1% gel","volume":"64","author":"RD Cranston","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pgph.0006422.ref008","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s10508-020-01880-y","article-title":"Exploring perceived barriers and facilitators of PrEP uptake among young people in Uganda, Zimbabwe, and South Africa","volume":"50","author":"R Muhumuza","year":"2021","journal-title":"Arch Sex Behav"},{"issue":"5","key":"pgph.0006422.ref009","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(24)00048-3","article-title":"Interventions that prevent or respond to intimate partner violence against women and violence against children: a systematic review","volume":"9","author":"LJ Bacchus","year":"2024","journal-title":"Lancet Public Health"},{"issue":"22","key":"pgph.0006422.ref010","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention in women","volume":"375","author":"JM Baeten","year":"2016","journal-title":"N Engl J Med"},{"issue":"22","key":"pgph.0006422.ref011","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and efficacy of a Dapivirine Vaginal Ring for HIV prevention in women","volume":"375","author":"A Nel","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"pgph.0006422.ref012","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/QAD.0000000000000280","article-title":"A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women","volume":"28","author":"A Nel","year":"2014","journal-title":"AIDS"},{"issue":"4","key":"pgph.0006422.ref013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284339","article-title":"A randomized trial of safety, acceptability and adherence of three rectal microbicide placebo formulations among young sexual and gender minorities who engage in receptive anal intercourse (MTN-035)","volume":"18","author":"JA Bauermeister","year":"2023","journal-title":"PLoS One"},{"key":"pgph.0006422.ref014","article-title":"Development of dapivirine vaginal ring for HIV prevention","author":"B Devlin","year":"2013","journal-title":"Antiviral Res"},{"issue":"11","key":"pgph.0006422.ref015","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25634","article-title":"Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo-controlled trial","volume":"23","author":"ER Brown","year":"2020","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"pgph.0006422.ref016","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/03630242.2019.1607803","article-title":"\u201cThe state of mind tells me it\u2019s dirty\u201d: menstrual shame amongst women using a vaginal ring in Sub Saharan Africa","volume":"60","author":"Z Duby","year":"2020","journal-title":"Women Health"},{"issue":"9","key":"pgph.0006422.ref017","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s10461-021-03231-x","article-title":"Correlates of adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention","volume":"25","author":"MJ Husnik","year":"2021","journal-title":"AIDS Behav"},{"key":"pgph.0006422.ref018","unstructured":"Majija L. Exploring young women\u2019s perceptions of the vaginal microbicide ring for preventing HIV in Johannesburg [Internet]. 2020 [cited 2024 Jun 11]. Available from: https:\/\/hdl.handle.net\/10539\/29956"},{"issue":"2","key":"pgph.0006422.ref019","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10461-019-02514-8","article-title":"Hygiene, blood flow, and vaginal overload: why women removed an HIV prevention vaginal ring during menstruation in Malawi, South Africa, Uganda and Zimbabwe","volume":"24","author":"Z Duby","year":"2020","journal-title":"AIDS Behav"},{"issue":"2","key":"pgph.0006422.ref020","article-title":"Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study","volume":"8","author":"A Nel","year":"2021","journal-title":"Lancet HIV"},{"issue":"3","key":"pgph.0006422.ref021","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/QAI.0000000000003496","article-title":"A review and economic analysis of the Dapivirine Vaginal Ring as HIV pre-exposure prophylaxis for women, to inform South African public-sector guidelines","volume":"97","author":"TD Leong","year":"2024","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"pgph.0006422.ref022","article-title":"Adherence to the Dapivirine Vaginal Ring among cisgender women in africa: protocol for a systematic review and meta-analysis","volume":"8","author":"RD Dine","year":"2025","journal-title":"Health Sci Rep"},{"issue":"1","key":"pgph.0006422.ref023","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"MJ Page","year":"2021","journal-title":"Syst Rev"},{"issue":"1","key":"pgph.0006422.ref024","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13643-021-01583-y","article-title":"Considerations for conducting systematic reviews: evaluating the performance of different methods for de-duplicating references","volume":"10","author":"S McKeown","year":"2021","journal-title":"Syst Rev"},{"issue":"2","key":"pgph.0006422.ref025","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(20)30304-0","article-title":"Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study","volume":"8","author":"JM Baeten","year":"2021","journal-title":"Lancet HIV"},{"issue":"9","key":"pgph.0006422.ref026","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"D Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"pgph.0006422.ref027","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: an update","volume":"28","author":"R DerSimonian","year":"2007","journal-title":"Contemp Clin Trials"},{"key":"pgph.0006422.ref028","unstructured":"Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data | Archives of Public Health | Full Text [Internet]. [cited 2024 Dec 17]. Available from: https:\/\/archpublichealth.biomedcentral.com\/articles\/10.1186\/2049-3258-72-39"},{"key":"pgph.0006422.ref029","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series","author":"JP Higgins"},{"issue":"1","key":"pgph.0006422.ref030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245498","article-title":"The effects of HIV self-testing on the uptake of HIV testing, linkage to antiretroviral treatment and social harms among adults in Africa: A systematic review and meta-analysis","volume":"16","author":"B Njau","year":"2021","journal-title":"PLoS One"},{"key":"pgph.0006422.ref031","unstructured":"Sch\u00fcnemann HJ, Bro\u017cek J, Guyatt G, Oxman A. GRADE handbook [Internet]. [cited 2025 Sep 23]. Available from: https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html"},{"issue":"7650","key":"pgph.0006422.ref032","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"GH Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"pgph.0006422.ref033","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/QAI.0000000000002990","article-title":"Patterns of adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial","volume":"90","author":"EN Browne","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"pgph.0006422.ref034","article-title":"Safety, acceptability and adherence of Dapivirine Vaginal Ring in a microbicide clinical trial conducted in multiple countries in Sub-Saharan Africa","volume":"11","author":"A Nel","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"pgph.0006422.ref035","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1007\/s10461-021-03286-w","article-title":"The influence of perceived Dapivirine Vaginal Ring effectiveness on social disclosure and ring adherence","volume":"25","author":"MCD Stoner","year":"2021","journal-title":"AIDS Behav"},{"issue":"5","key":"pgph.0006422.ref036","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/QAI.0000000000001866","article-title":"Impact of partner-related social harms on women\u2019s adherence to the Dapivirine Vaginal Ring during a phase III trial","volume":"79","author":"T Palanee-Phillips","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"pgph.0006422.ref037","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1007\/s10461-024-04382-3","article-title":"Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034\/REACH Trial","volume":"28","author":"K Ngure","year":"2024","journal-title":"AIDS Behav"},{"issue":"5","key":"pgph.0006422.ref038","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1007\/s10461-019-02707-1","article-title":"Impact of male partner involvement on women\u2019s adherence to the Dapivirine Vaginal Ring during a phase III HIV prevention trial","volume":"24","author":"ST Roberts","year":"2020","journal-title":"AIDS Behav"},{"issue":"8","key":"pgph.0006422.ref039","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1007\/s10461-021-03205-z","article-title":"Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial","volume":"25","author":"AJ Mayo","year":"2021","journal-title":"AIDS Behav"},{"issue":"12","key":"pgph.0006422.ref040","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(23)00227-8","article-title":"Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial","volume":"10","author":"G Nair","year":"2023","journal-title":"Lancet HIV"},{"issue":"3","key":"pgph.0006422.ref041","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s10461-021-03434-2","article-title":"Integration of a relationship-focused counseling intervention with delivery of the dapivirine ring for HIV prevention to women in johannesburg: results of the CHARISMA Pilot Study","volume":"26","author":"ET Montgomery","year":"2022","journal-title":"AIDS Behav"},{"issue":"11","key":"pgph.0006422.ref042","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1007\/s10461-024-04463-3","article-title":"Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence","volume":"28","author":"MJ Husnik","year":"2024","journal-title":"AIDS Behav"},{"issue":"1","key":"pgph.0006422.ref043","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1186\/s12889-021-11919-x","article-title":"Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020\/ASPIRE study","volume":"21","author":"M Garcia","year":"2021","journal-title":"BMC Public Health"},{"key":"pgph.0006422.ref044","unstructured":"Microbicide Trials Network (MTN). Study suggests dapivirine vaginal ring is safe to use as HIV prevention during breastfeeding | Microbicide Trials Network [Internet]. [cited 2024 Jul 18]. Available from: https:\/\/www.mtnstopshiv.org\/news\/study-suggests-dapivirine-vaginal-ring-safe-use-hiv-prevention-during-breastfeeding"},{"issue":"1","key":"pgph.0006422.ref045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/QAI.0000000000003312","article-title":"DELIVER: a safety study of a dapivirine vaginal ring and oral PrEP for the prevention of HIV during pregnancy","volume":"95","author":"K Bunge","year":"2024","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"1","key":"pgph.0006422.ref046","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1186\/s12905-024-03516-y","article-title":"Barriers to PrEP use and adherence among adolescent girls and young women in Eastern, Southern, and Western Africa: a scoping review","volume":"24","author":"M Admassu","year":"2024","journal-title":"BMC Womens Health"},{"issue":"6","key":"pgph.0006422.ref047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003670","article-title":"PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial","volume":"18","author":"C Celum","year":"2021","journal-title":"PLoS Med"},{"key":"pgph.0006422.ref048","unstructured":"European Medicines Agency. Dapivirine Vaginal Ring 25\u2009mg | European Medicines Agency [Internet]. [cited 2024 Jun 11]. Available from: https:\/\/www.ema.europa.eu\/en\/opinion-medicine-use-outside-EU\/human\/dapivirine-vaginal-ring-25-mg"},{"issue":"10","key":"pgph.0006422.ref049","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(22)00195-3","article-title":"Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial","volume":"9","author":"J Velloza","year":"2022","journal-title":"Lancet HIV"},{"issue":"11","key":"pgph.0006422.ref050","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26189","article-title":"How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub-Saharan Africa: a mixed methods analysis","volume":"26","author":"ST Roberts","year":"2023","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"pgph.0006422.ref051","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s10461-019-02521-9","article-title":"Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020\/ASPIRE Trial","volume":"24","author":"E Pleasants","year":"2020","journal-title":"AIDS Behav"},{"issue":"1","key":"pgph.0006422.ref052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0312957","article-title":"Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030\/IPM 041 and MTN-044\/IPM 053\/CCN019): Implications for multipurpose prevention technology development","volume":"20","author":"BA Friedland","year":"2025","journal-title":"PloS One"},{"issue":"1","key":"pgph.0006422.ref053","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1186\/s12889-024-18795-1","article-title":"Self-reported removal and expulsion of the dapivirine vaginal ring: qualitative reports from female ring users and their male partners in the Ring Study (IPM 027)","volume":"24","author":"C Milford","year":"2024","journal-title":"BMC Public Health"},{"key":"pgph.0006422.ref054","article-title":"Non-adherence among women enrolled in a contraceptive vaginal ring use study in Kisumu, Kenya, 2014-2015","volume":"2","author":"E McLellan-Lemal","year":"2018","journal-title":"J Glob Health Rep"},{"issue":"11","key":"pgph.0006422.ref055","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/QAD.0000000000001868","article-title":"Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results","volume":"32","author":"ET Montgomery","year":"2018","journal-title":"AIDS"},{"issue":"3","key":"pgph.0006422.ref056","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/apc.2022.0002","article-title":"Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women","volume":"36","author":"MK Shapley-Quinn","year":"2022","journal-title":"AIDS Patient Care STDS"},{"issue":"6","key":"pgph.0006422.ref057","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s10389-021-01617-8","article-title":"Youth health risk behavior: effects of early sexual debut on HIV incidence among Rwandan youth","volume":"31","author":"RD Dine","year":"2021","journal-title":"J Public Health (Berl)"},{"issue":"6","key":"pgph.0006422.ref058","article-title":"Ten simple rules for successful and sustainable African research collaborations","volume":"20","author":"RD Dine","year":"2024","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"pgph.0006422.ref059","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1186\/s12913-020-05556-0","article-title":"Availability, accessibility, and quality of adolescent Sexual and Reproductive Health (SRH) services in urban health facilities of Rwanda: a survey among social and healthcare providers","volume":"20","author":"P Ndayishimiye","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"pgph.0006422.ref060","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1186\/s12913-023-10142-1","article-title":"Assessment of the availability, accessibility, and quality of sexual and reproductive health services for young people in conflict affected zones of Cameroon: a mixed method study","volume":"23","author":"RD Dine","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"pgph.0006422.ref061","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s10461-024-04321-2","article-title":"Depression Among Pregnant and Breastfeeding Persons Participating in Two Randomized Trials of the Dapivirine Vaginal Ring and Oral Pre-Exposure Prophylaxis (PrEP) in Malawi, South Africa, Uganda, and Zimbabwe","volume":"28","author":"MCD Stoner","year":"2024","journal-title":"AIDS Behav"},{"key":"pgph.0006422.ref062","unstructured":"Nel A, Van Niekerk N, Van Baelen B, Rosenberg Z. HIV incidence and adherence in dream: An open-label trial of dapivirine vaginal ring. 2018."},{"issue":"8","key":"pgph.0006422.ref063","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/QAD.0000000000001452","article-title":"Acceptability and use of a dapivirine vaginal ring in a phase III trial","volume":"31","author":"ET Montgomery","year":"2017","journal-title":"AIDS"},{"key":"pgph.0006422.ref064","unstructured":"Choice and Adherence to Dapivirine Ring or Oral PrEP by Young African Women in REACH: 67% prefer ring vs 31% oral PrEP [Internet]. [cited 2025 Apr 23]. Available from: https:\/\/www.natap.org\/2022\/CROI\/croi_90.htm"},{"key":"pgph.0006422.ref065","volume-title":"Implementing a rapid response to the COVID-19 global pandemic in MTN-034\/REACH: An HIV prevention trial among adolescent girls and young women in Africa","author":"T McClure","year":"2021"},{"key":"pgph.0006422.ref066","article-title":"4th HIV Research for Prevention conference (HIVR4P\/\/ Virtual), 27 & 28 January | 3 & 4 February 2021","volume":"24","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"pgph.0006422.ref067","article-title":"4th HIV Research for Prevention conference (HIVR4P\/\/ Virtual), 27 & 28 January | 3 & 4 February 2021","volume":"24","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"pgph.0006422.ref068","first-page":"1","article-title":"Abstracts of the HIV Research for Prevention Meeting, HIVR4P, 17-20 October, 2016, Chicago, USA","volume":"32","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pgph.0006422.ref069","unstructured":"Abstracts of the HIV Research for Prevention Meeting, HIVR4P, 21-25 October, 2018, Madrid | AIDS Research and Human Retroviruses [Internet]. [cited 2025 Apr 23]. Available from: https:\/\/www.liebertpub.com\/doi\/10.1089\/aid.2018.5000.abstracts"},{"key":"pgph.0006422.ref070","doi-asserted-by":"crossref","first-page":"2325958219892705","DOI":"10.1177\/2325958219892705","article-title":"Oral abstracts from adherence 2019 conference","volume":"19","year":"2020","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"pgph.0006422.ref071","article-title":"Oral abstracts of the 10th IAS Conference on HIV Science, 21-24 July 2019, Mexico City, Mexico","volume":"22","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"pgph.0006422.ref072","article-title":"Oral abstracts of the 11th IAS Conference on HIV Science, 18-21 July 2021","volume":"24","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"pgph.0006422.ref073","unstructured":"Glaubius R, Penrose KJ, Hood G, Parikh UM, Abbas U. Dapivirine vaginal ring preexposure prophylaxis for HIV prevention in South Africa."},{"key":"pgph.0006422.ref074","unstructured":"Ndagire AK, Onyango M, Bayigga J, Aling E, Kusemererwa S. Examining the relationship between multiple sexual partners and adherence to the dapivirine vaginal ring in a trial in South Western Uganda. 2018."},{"key":"pgph.0006422.ref075","unstructured":"Baeten JM, Palanee-Philips T, Mgodi N, Mayo A, Nel A, Rosenberg Z. High uptake and reduced HIV-1 incidence in an open-label trial of the dapivirine ring. 2018."},{"key":"pgph.0006422.ref076","unstructured":"Brown E, Palanee-Philips T, Marzinke MA, Hendrix CW, Dezutti C, Soto-Torres LE, et al. Residual dapivirine ring levels indicate higher adherence to vaginal ring is associated with HIV\u20101 protection. 2023."},{"issue":"2","key":"pgph.0006422.ref077","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/QAI.0000000000003110","article-title":"Brief report: Dapivirine ring HIV-1 prevention effectiveness for women engaged in vaginal and anal intercourse: insights from mathematical modeling","volume":"92","author":"K Peebles","year":"2023","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"pgph.0006422.ref078","article-title":"Advancing the use of Long-Acting Extended Delivery formulations for HIV prevention in sub-Saharan Africa: challenges, opportunities, and recommendations","author":"NM Mgodi","year":"2023","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"pgph.0006422.ref079","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1521\/aeap.2019.31.5.433","article-title":"Generating CHARISMA: Development of an Intervention to Help Women Build Agency and Safety in Their Relationships While Using PrEP for HIV Prevention","volume":"31","author":"M Hartmann","year":"2019","journal-title":"AIDS Educ Prev"},{"key":"pgph.0006422.ref080","unstructured":"Montgomery ET, Roberts S, Reddy K, Tolley E, Hartmann M, Wilson E, et al. Impact of the?charisma? intervention pilot on partner disclosure, IPV, and adherence [Internet]. 2020. Available from: https:\/\/regroup-production.s3.amazonaws.com\/documents\/ReviewReference\/1126287899\/1430_3_Montgomery_01015.pdf?response-content-type=application%2Fpdf&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAYSFKCAWYQ4D5IUHG%2F20250423%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20250423T121352Z&X-Amz-Expires=604800&X-Amz-SignedHeaders=host&X-Amz-Signature=27d4d1e9bcd5a6338d60c27f1ef1915b558b11c078b10d20b1c6aa2536853d31"},{"key":"pgph.0006422.ref081","article-title":"Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring","author":"RM Stalter","year":"2023","journal-title":"J Acquired Immune Deficiency Syndromes"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:34:13Z","timestamp":1779125653000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006422"}},"subtitle":[],"editor":[{"given":"Janet","family":"Seeley","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":81,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0006422","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]}}}